Physician profile
Benjamin D Lahood
NPI 1275055709
$953.29
in general payments reported to CMS, 2019-2025
15 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $32.69 · 2021: $228 · 2022: $119 · 2023: $234 · 2024: $74.71 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $194.03 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $188.25 | 2021-2023 | Xarelto |
| Braeburn INC. | $145.30 | 2023 | Brixadi |
| Novo Nordisk INC | $109.33 | 2021-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $95.06 | 2022-2025 | |
| Amgen INC. | $38.01 | 2023 | Otezla, Repatha |
| Jazz Pharmaceuticals INC. | $35.98 | 2025 | |
| Smith+Nephew, INC. | $27.29 | 2025 | Collagenase Santyl |
| Avanos Medical | $22.77 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.15 | 2025 | Koselugo |
| Insulet Corporation | $17.00 | 2023 | Omnipod |
| Exact Sciences Corporation | $16.47 | 2025 | Cologuard Collection Kit |
| Indivior INC. | $14.51 | 2025 | Sublocade |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.23 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lahood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.